SCOPUS 정보 검색 플랫폼

Pharmacoepidemiology and Drug Safety

Volumn 10, Issue 5, 2001, Pages 429-438

'Fourth hurdle reviews', NICE, and database applications

(2) Paul, John E a,b Trueman, Paul a

a RTI HEALTH SOLUTIONS (United States)

b JOHNSON AND JOHNSON (United States)

Author keywords

Clinical effectiveness; Cost effectiveness; Database applications; Drug approval guidelines; Fourth hurdle; NICE

Indexed keywords

DRUG;

ARTICLE; BIOTECHNOLOGY; CLINICAL STUDY; COST EFFECTIVENESS ANALYSIS; DATA BASE; DRUG DEVELOPMENT; DRUG EFFICACY; DRUG MANUFACTURE; DRUG MARKETING; DRUG QUALITY; DRUG SAFETY; GOVERNMENT; HEALTH CARE ORGANIZATION; MEDICAL TECHNOLOGY; MODEL; MONEY; PRIORITY JOURNAL; REIMBURSEMENT; RESOURCE ALLOCATION; UNITED KINGDOM; UTILIZATION REVIEW;

COST-BENEFIT ANALYSIS; DATABASES; DRUG APPROVAL; DRUG EVALUATION; GREAT BRITAIN; HUMANS; NATIONAL HEALTH PROGRAMS; OUTCOME ASSESSMENT (HEALTH CARE); POLICY MAKING; STATE MEDICINE; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 0035215173 PISSN: 10538569 EISSN: None Source Type: Journal
DOI: 10.1002/pds.600 Document Type: Article

Times cited : (30)

References (20)

1
- 0003581384
- Office of Health Economics: London
- (1997) Drivers of the Growth in Medicines Expenditure
- Marchant, N.¹

2
- 0003665913
- Department of Health. Department of Health: Cm 3807, December
- (1997) The New NHS Modern Dependable

3
- 0003674346
- Faster Access to Modern Treatment: How NICE Appraisal will Work: A Discussion Paper
- NHS Executive. NHS Executive, Leeds, January
- (1999)

4
- 0003602057
- Appraisal of New and Existing Technologies: Interim Guidance for Manufacturers and Sponsors
- National Institute for Clinical Excellence. National Institute for Clinical Excellence, December
- (1999)

5
- 0003701694
- Sheffield Health Economics Group, Discussion paper 99/1
- (1999) Obtaining the Q in QALYs: A Comparison of Five Multi-attribute Utility Scales
- Brazier, J.¹ Deverill, M.²

6
- 0032813526
- Death by questionnaire: Quality of life measurement could seriously damage your health
- (1999) J Health Ser Res Policy , vol.4 , pp. 129-130
- Jenkinson, C.¹

7
- 0033009053
- Research into the use of health economics in decision-making in the United Kingdom-Phase II: Is health economics 'for good or evil'
- (1999) Health Policy , vol.46 , pp. 143-157
- Duthie, T.¹ Trueman, P.² McCann, C.³ Chancellor, J.⁴

8
- 0003550938
- editors. Radcliffe Medical Press: Abingdon Oxon
- (1997) Making Choices for Health Care
- Honigsbaum, F.¹ Holstrom, S.² Calltorp, J.³

9
- 0031725185
- Estimating country-specific cost effectiveness from multi-national clinical trials
- (1998) Health Econ , vol.7 , pp. 481-493
- Willke, R.A.¹ Glick, H.A.² Polsky, D.³ Schulman, K.⁴

10
- 0033608837
- NICE: A step forward in the quality of NHS care
- (editorial)
- (1999) The Lancet , vol.353 , pp. 1028-1029
- Horton, R.¹

11
- 0004234941
- PRODIGY Phase Two: Report on the Result of Prodigy Phase Two
- Department of Health. Newcastle Sowerby Centre for Health Informatics: Newcastle
- (1998)

12
- 0006992202
- Commonwealth Department of Human Services and Health. Guidelines for the Pharmaceutical Industry on the Preparation of Submissions to the Pharmaceutical Benefits Advisory Committee. Commonwealth Department of Health: Canberra, Australia, November
- (1995)

13
- 0006950257
- Ontario Ministry of Health. Ontario Guidelines for Economic Analysis of Pharmaceutical Products. Ministry of Health: Ontario
- (1994)

14
- 0003866632
- Canadian Co-ordinating Office for Health Technology Assessment (CCOHTA). 2nd edn. CCOHTA: Ottawa
- (1997) Guidelines for Economic Evaluation of Pharmaceuticals: Canada

15
- 0003504820
- Blue Cross Blue Shield of Colorado/Blue Cross Blue Shield of Nevada: Denver
- (1998) Guidelines for Formulary Submissions for Pharmaceutical Product Evaluation
- Langley, P.C.¹

16
- 0000504235
- Criteria for making coverage decisions
- Health Care Financing Administration. US DHHS
- (2000) Fed Reg , vol.65 , pp. 31124-31129

17
- 0006904556
- Drug trials must adapt to show value for money: Health institute wants principles on cost-effectiveness developed
- Anonymous. Tuesday 19 October
- (1999) Financial Times

18
- 7144259074
- Use of the UK General Practice Research Database for pharmacoepidemiology
- (1998) Brit J Pharm , vol.45 , pp. 419-425
- Garcia Rodriguez, L.A.¹ Perez Guthann, S.²

19
- 0006902051
- The Pharmaceutical R & D Compendium. CMR International's/Scrip's Compete Guide to Trends in R & D: Centre for Medicines Research/Scrip Report. PJB Publications: Richmond, Surrey
- (1999)

20
- 0004242275
- The Harmonisation by Consensus of the Methodology for Economic Evaluation of Health Care Technologies in the European Union
- European Commission and Universidad de Barcelona; September
- (1997)
- Rovira, J.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.